BIO.B
NYSE Bio-Rad Laboratories, Inc. Class B$365.08
- YTD change
- +0.00%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+88.08 (+31.80%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 0.0% away from all-time highs of $365.08
- BIO.B is up 0% since the beginning of the year
- BIO.B is up 0% over the past 12 months
- BIO.B is up 0% over the past 1 month
BIO.B reads n/a: the 12-month move is +13.7%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +0.00%
- vs 8-day SMA
- N/A
No alerts for BIO.B in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.